InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 10/29/2020 9:30:19 PM

Thursday, October 29, 2020 9:30:19 PM

Post# of 3836
JUST IN: $GNPX Genprex Receives Conditional FDA Acceptance of Proprietary Name REQORSA(TM) for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer

Approval of new name marks important branding milestone and aligns with the program’s overall progress REQORSA immunogene therapy uses the company’s unique, proprietary ONCOPREX™ nanoparticle delivery system to deliver cancer-fighting genes FDA gra...

Read the whole news GNPX - Genprex Receives Conditional FDA Acceptance of Proprietary Name REQORSA(TM) for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer

@whytestocks

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GNPX News